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Abstract 
 
 The sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) pumps are 
approximately 100 kDa transmembranous proteins that catalyze the ATP-
dependent transport of cytosolic Ca2+ [Ca2+]i into the sarcoplasmic reticulum 
(SR), thereby maintaining low concentrations of resting [Ca2+]i. Reactive free- 
and non-radical oxygen and nitrogen species regulate SERCA function. 
Additionally, free radicals can oxidize lipids producing bioactive lipid-
peroxidation end-products which are capable of modifying membranous 
proteins, resulting in protein inactivation. Here, in order to characterize the 
effect of 4-HNE, a lipid-peroxidation end-product, on SERCA structure and 
function, mouse WG and LV tissues were treated with 4-HNE and 
subsequently assayed for maximal Ca2+-dependent SERCA activity and SERCA 
post-translational structural modifications. Ca2+-dependent, maximal SERCA 
activity assays demonstrate a dose-dependent functional impairment of the 
SERCA pumps following 4-HNE treatment; interestingly, western blotting 
revealed significant increases in 4-HNE – SERCA1a adduction. Moreover, blots 
illustrated that the SERCA inhibition by 4-HNE may be independent of 
nitrosative stress as there were no evident increases in total protein 
nitrotyrosine or SERCA specific nitrotyrosine formation with 4-HNE treatment. 
Additionally, there were no observed increases in total protein 
glutathionylation or SERCA specific glutathionylation with 4-HNE treatment. 
The impairments in SERCA function are likely due to increased SERCA 
aggregation as revealed by a significant reduction in monomeric SERCA in 
both isoforms, confirmed by results illustrating a significant increase in higher 
molecular weight SERCA aggregates. Immunoprecipitation of SERCA revealed 
reduced FITC binding to the SERCA1a isoform with no changes to the 
SERCA2a isoform, illustrating isoform specific structural changes following 4-
HNE treatment. These results demonstrate that the reactive lipid-peroxidation 
end-product, 4-HNE, can directly impair SERCA function by potentially 
causing isoform specific structural changes. 
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Introduction 
 
Calcium (Ca) is one of 118 known chemical elements and is the 5th 
most abundant element in the human body by mass (Wittmann, Lohse, 
& Schmitt, 2015). Aside from Ca being a key constituent in the skeletal 
bones of all vertebrates, ionic calcium (Ca2+) participates in numerous 
cellular processes. As a ubiquitous cellular signaling molecule, Ca2+ 
participates in: basic signal transduction (Fedrizzi, Lim, & Carafoli, 
2008), growth and death signaling (Decuypere et al., 2011; Li, Zhao, Wei, 
Zhao, & Chen, 2011), metabolic signaling (Bal et al., 2012; Bombardier et 
al., 2013; Gamu, Bombardier, Smith, Fajardo, & Tupling, 2014), and 
muscular contraction in skeletal and cardiac muscle (Gordon, Regnier, & 
Homsher, 2001). The ubiquitous role of Ca2+ as a signaling molecule has 
an associated complexity, whereby the movement of Ca2+ functions as a 
physiological signal for a multitude of cellular processes. Therefore, due 
to its complexity as a messenger, the movement and 
compartmentalization of Ca2+ must be finely tuned with proteins, acting 
as ion-channels and pumps regulating the movement of Ca2+, and innate 
membranous structures, serving as a way to compartmentalize and store 
Ca2+ when it is not involved in cellular signaling.  
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The role of Ca2+ and the sarcoplasmic reticulum in excitation-contraction 
coupling 
Briefly, skeletal muscle contraction involves a sequence of events 
that results in contraction-relaxation cycles and is collectively labelled 
excitation-contraction (EC) coupling. Initially, EC coupling begins with a 
depolarizing stimulus at the neuromuscular junction. Upon 
depolarization, propagation of the stimulus ensues and occurs through 
rapid signal transduction across the sarcolemmal membrane, eventually 
reaching the transverse-tubules (t-tubules). At the t-tubules, the change 
in voltage (depolarization) detected by the voltage-sensitive 
dihydropyridine receptors (DHPRs) causes the rapid release of Ca2+ from 
the sarcoplasmic reticulum (SR) store via the ryanodine receptors (RyRs), 
a process labelled voltage-dependent calcium release (VDCR). The 
release of Ca2+ through the RyRs is due to the physical coupling between 
the DHPRs and RyRs, collectively labelled the calcium-release units. The 
resulting increase in intracellular Ca2+ ([Ca2+]i) initiates skeletal muscle 
contraction (Leong & MacLennan, 1998).  
Contraction in cardiac muscle slightly differs from skeletal muscle 
in a few respects. Importantly, EC coupling in cardiac tissue is chemical 
3 
 
in nature, whereby during a cardiac action potential extracellular Ca2+ 
enters the cell through DHPRs and initiates a process known as calcium-
induced calcium-release (CICR); Ca2+ entry from the extracellular 
compartment through the DHPRs stimulates the release of Ca2+ from the 
SR store, initiating cardiac muscular contraction (Bers, 2002). The 
significance of the SR in both of these muscle types is that it is the 
primary site of Ca2+ storage within skeletal and cardiac tissue. This makes 
it a key structure as it pertains to EC coupling, allowing for Ca2+ release 
and subsequent muscular contraction.  
The role of the sarco(endo)plasmic reticulum Ca2+-ATPase pumps in excitation-
contraction coupling 
As the SR plays an integral role in muscular contraction, it is also 
intimately involved in muscular relaxation, acting as a fast Ca2+ sink for 
the rapid removal of [Ca2+]i and initiating muscular relaxation. In skeletal 
and cardiac muscle, relaxation is predominately regulated through the 
action of the sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) pumps 
(Bers, 2002; MacLennan, Rice, & Green, 1997) which are directly 
embedded within the SR membrane. The transmembrane SERCA pumps 
are classified as auto-phosphorylatable ATPases (P-type ATPases) that 
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electrophoretically migrate at approximately 100 kDa. Structurally, 
SERCA pumps consist of 10 transmembrane helices (M1-M10), three 
cytoplasmic domains (actuator, nucleotide-binding and phosphorylation 
domains), and small luminal loops (Brandl, Green, Korczak, & 
MacLennan, 1986; Menguy et al., 1998; Toyoshima, Nakasako, Nomura, 
& Ogawa, 2000). Collectively, these domains catalyze the ATP-
dependent transport of [Ca2+]i into the lumen of the SR (MacLennan, 
Abu-Abed, & Kang, 2002). SERCA pumps are primarily responsible for 
regulating resting [Ca2+]i concentrations and initiating muscular 
relaxation (Bers, 2002; Rossi & Dirksen, 2006; Tupling, 2009). Specifically, 
in skeletal muscle, the SERCA pumps sequester large [Ca2+]i loads from 
the cytoplasm into the SR lumen and maintain the approximately 10,000-
fold concentration gradient across the SR membrane (~ 0.1 µM in the 
cytosol and ~ 1,000 µM in the SR lumen) at rest (Rasmussen & Barrett, 
1984), roughly a 4 order of magnitude difference. This steep 
concentration gradient maintained by the SERCA pumps is the 
predominant driving force by which Ca2+ exits the SR through the RyRs 
to elicit muscular contraction.  
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SERCA pumps are regulated through redox-signaling 
 In vertebrates, three distinct genes encode SERCA pumps: 
SERCA1, SERCA2 and SERCA3 are encoded by ATP2A1, ATP2A2 and 
ATP2A3, respectively, and alternative splicing generates multiple 
SERCA isoforms (SERCA1a,b, SERCA2a-c and SERCA3a-f) (Hovnanian, 
2007). In adult striated muscle, two SERCA isoforms predominate, 
namely SERCA1a and SERCA2a (East, 2000). SERCA1a is expressed 
almost exclusively in adult fast-twitch skeletal muscle fibres whereas 
SERCA2a is expressed both in cardiac and slow-twitch skeletal muscle 
(Wu & Lytton, 1993). SERCA1a is 994 amino-acids long while SERCA2a 
is 997 amino-acids and has approximately 84% identical amino-acid 
sequence to SERCA1a (Brandl et al., 1986). Several amino-acids critical to 
SERCA function have been identified through mutagenesis studies 
(Andersen, Clausen, Einholm, & Vilsen, 2003; Clausen & Andersen, 2003; 
Clausen, McIntosh, Vilsen, Woolley, & Andersen, 2003; MacLennan, 
Clarke, Loo, & Skerjanc, 1992; MacLennan et al., 1997; McIntosh et al., 
2003; Menguy et al., 1998), some of which have been identified as 
primary targets for oxidative modification through carbonylation, 
nitrosylation, and glutathionylation in both mass-spectrometry (MS) 
(Schöneich & Sharov, 2006) and labeling (Fu & Tupling, 2009; Tupling et 
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al., 2004) experiments. Interestingly, studies have demonstrated that 
SERCA is differentially regulated through redox signaling as oxidants at 
low concentrations stimulate SERCA function (Adachi, 2010; Adachi et 
al., 2004; Cohen et al., 1999; Lancel et al., 2009; Smith et al., 2015; Tong et 
al., 2008; Tong, Evangelista, & Cohen, 2010; Trepakova, Cohen, & 
Bolotina, 1999; Tupling et al., 2007; Ying et al., 2007), whereas oxidants at 
high concentrations impair SERCA function (Adachi, 2010; Adachi et al., 
2004; Cohen & Adachi, 2006; Gutiérrez-Martín, Martín-Romero, Iñesta-
Vaquera, Gutiérrez-Merino, & Henao, 2004; Klebl, Ayoub, & Pette, 1998; 
Knyushko, Sharov, Williams, Schöneich, & Bigelow, 2005; Kuster et al., 
2010; Lancel et al., 2010; Senisterra et al., 1997; Viner, Ferrington, 
Hühmer, Bigelow, & Schöneich, 1996; Viner, Williams, & Schöneich, 
1999; Xu, Zweier, & Becker, 1997). One amino acid, Cys674, has been 
identified as an important redox-sensitive target that may function as 
SERCA’s biological-switch, whereby reversible oxidation of Cys674 
increases SERCA activity and irreversible oxidation impairs SERCA 
activity (Adachi, 2010; Adachi et al., 2004; Cohen et al., 1999; Lancel et al., 
2009; Smith et al., 2015; Tong et al., 2008; Tong et al., 2010; Trepakova et 
al., 1999; Tupling et al., 2007; Ying et al., 2007). Additionally, lysine (Lys), 
tyrosine (Tyr), methionine (Met), and histidine (His) residues have also 
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been illustrated as oxidative sensitive targets; whereby, oxidation of 
these residues impairs SERCA function (Ahsan, 2013; Schöneich & 
Sharov, 2006; Stadtman & Levine, 2003; Tien, Berlett, Levine, Chock, & 
Stadtman, 1999). 
SERCA impairment is often associated with oxidative damage to 
its cytoplasmic domains. A significant portion of SERCA’s readily 
oxidized Cys residues, including Cys674, are cytoplasmic and freely 
accessible to water-soluble oxidants (Ariki & Shamoo, 1983; Senisterra et 
al., 1997). In addition to the irreversible oxidation of Cys674, oxidative 
damage to the nucleotide-binding domain (N-domain) also results in 
SERCA inactivation (Fu & Tupling, 2009; Luckin, Favero, & Klug, 1991; 
Matsushita & Pette, 1992; Tupling et al., 2004; Tupling, Green, Senisterra, 
Lepock, & McKee, 2001). In fact, when SERCA is exposed to oxidative 
stress, preservation of the structural integrity of the N-domain, as 
measured through fluorescein isothiocyanate (FITC) binding assays, is 
correlated with preserved SERCA function (Fu and Tupling, 2009; 
Tupling et al., 2004). FITC is a fluorescent probe that covalently labels 
Lys515 (SERCA1a) (Pick & Karlish, 1980) or Lys514 (SERCA2a) (Fu & 
Tupling, 2009) located close to the ATP-binding site (Toyoshima et al., 
2000). Therefore, oxidative damage to SERCA through irreversible 
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oxidation and/or through structural alterations of the pump results in 
SERCA impairment, as illustrated in myocardial ischemia (Temsah et al., 
1999; Tupling et al., 2001), cardiovascular disease (Hobai et al., 2013; 
Knyushko et al., 2005), heat stress (Fu & Tupling, 2009; Schertzer, Green, 
& Tupling, 2002; Tupling et al., 2004), myopathies (Fajardo et al., 2015; 
Gehrig et al., 2012), and atherosclerosis (Adachi et al., 2004; Cohen & 
Adachi, 2006). 
Although the SERCA isoforms have a high degree of sequence 
homology, it appears that distinctive protein modifications occur in 
different isoforms in response to oxidative stress (Barnes, Samson, & 
Grover, 2000; Grover, Kwan, & Samson, 2003; Grover, Samson, & 
Misquitta, 1997; Viner et al., 1996). Interestingly, there is evidence that 
SERCA2 is more susceptible to oxidation than other SERCA isoforms. It 
has been demonstrated that in vitro exposure of SR vesicles to 
peroxynitrite (ONOO ¯) yielded selective oxidation of SERCA2a in the 
presence of both SERCA2a and SERCA1a isoforms, even with excess 
SERCA1a protein (Viner et al., 1996). Additionally, several studies have 
demonstrated that SERCA3 is more resistant to oxidants than the 
SERCA2b isoform (Grover et al., 2003; Grover et al., 1997). A potential 
explanation for the increased sensitivity of SERCA2 towards oxidative 
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modifications when compared to the other SERCA isoforms is that with 
26 Cys residues, SERCA2 has the highest number of the readily oxidized 
sulfonyl groups when compared to the other SERCA isoforms (Menguy 
et al., 1998; Senisterra et al., 1997); thereby, potentially providing 
SERCA2 with increased sensitivity towards oxidative regulation. 
4-hydroxy-2-nonenal: A major product of lipid-peroxidation 
 In addition to oxidizing proteins, free-radicals readily oxidize 
polyunsaturated fatty acids (PUFAs). The mechanism of free-radical 
mediated lipid peroxidation (oxidation of lipids) consists of three distinct 
phases: initiation, propagation and termination (Porter, Caldwell, & 
Mills, 1995) (Figure 1). During the initiation phase, lipid peroxidation 
begins when free-radicals oxidize PUFAs, resulting in the formation of 
lipid radicals. PUFAs are particularly vulnerable to oxidation because 
they contain carbon-carbon double bonds with allylic hydrogens that are 
easily oxidized, resulting in the formation of resonance-stabilized lipid 
radicals (Ayala, Munoz, & Arguelles, 2014; Porter et al., 1995). 
Subsequently, the propagation of lipid peroxidation involves these 
newly generated lipid radicals reacting with oxygen to form lipid 
peroxyl radicals (Ayala et al., 2014). Lipid peroxyl radicals are extremely 
10 
 
 
 
 
Figure 1: Simplified schematic illustrating the mechanism of non-enzymatic, free-radical mediated 4-HNE production and protein 
modification. 
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unstable and further react with other PUFAs, producing a lipid 
hydroperoxide product and a new lipid radical that further propagates 
the lipid peroxidation cascade (Ayala et al., 2014). The termination of 
lipid peroxidation occurs through naturally occurring antioxidant 
systems that reduce lipid radicals and stop the propagation of lipid 
peroxidation, the most notable with respect to 4-HNE is the cytosolic 
antioxidant glutathione (GSH) (Sinha-Hikim et al., 2011). 
The lipid hydroperoxides that are generated as a result of lipid 
peroxidation are highly unstable and immediately decompose into 
secondary aldehydic products. The major secondary aldehydic products 
produced from lipid hydroperoxides are 4-hydroxy-2-nonenal (4-HNE), 
malondialdehyde (MDA), and acrolein (ACR) which are all considered 
to be α,β-unsaturated hydroxyalkenals (Ayala et al., 2014). Secondary 
aldehydic products are considered to be second messengers of free-
radicals because they can bind to biomolecules and propagate free-
radical signaling (Ayala et al., 2014). Notably, out of the three major end 
products, pioneering work in the 1980s by H. Esterbauer and colleagues 
has demonstrated that 4-HNE is produced in abundance and is the 
second most reactive product out of the three (Benedetti, Comporti, & 
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Esterbauer, 1980; Esterbauer, 1993; Esterbauer, Wäg, & Puhl, 1993; 
Schauenstein & Esterbauer, 1978).  
4-HNE can functionally modify transmembrane proteins 
 4-HNE was first discovered in 1967 (Schauenstein, 1967) and it is 
produced from the oxidation of long chain ( ≥ 18 carbons in length), 
omega-6 (ω-6), polyunsaturated fatty acids (PUFAs), more specifically, 
arachidonic acid (AA) 20:4(ω-6), linoleic acid (LA) 18:2(ω-6) and γ-
linolenic acid (GLA) 18:3(ω-6) (Ayala et al., 2014; Poli, Biasi, & 
Leonarduzzi, 2008; Poli, Schaur, Siems, & Leonarduzzi, 2008; Pryor & 
Porter, 1990; Riahi, Cohen, Shamni, & Sasson, 2010; Schneider, Tallman, 
Porter, & Brash, 2001; Uchida, 2003; Uchida, Szweda, Chae, & Stadtman, 
1993). 4-HNE has a unique molecular structure containing a carbon-
carbon double bond, a hydroxyl group and an aldehydic functional 
group, which all collectively contribute to its strong electrophilic 
characteristics (Ayala et al., 2014). Due to its strong electrophilic 
characteristics, 4-HNE rapidly reacts with nucleophilic regions of 
proteins through direct protein adduction (Petersen & Doorn, 2004; 
Stadtman & Levine, 2003). In an excellent review, Madian and Regnier 
describe how proteins can be oxidized in more than 35 different ways, 
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and that these post-translational protein modifications can be divided 
into three specific categories; protein adduction by the end products of 
lipid peroxidation was identified as one of the three classifications 
(Madian & Regnier, 2010). Interestingly, similar to free-radicals, 4-HNE 
rapidly oxidizes Cys, His, and Lys residues (Petersen & Doorn, 2004; 
Schaur, 2003).  
The electrophilic and lipophilic characteristics of 4-HNE places 
membranous proteins vulnerable to 4-HNE adduction, particularly 
because of their close proximity to the site of 4-HNE production.  
Interestingly, 4-HNE adduction onto the Na+/K+ pump leads to a dose-
dependent inactivation of the enzyme (Morel, Tallineau, Pontcharraud, 
Piriou, & Huguet, 1998; Siems, Hapner, & Kuijk, 1996). The Na+/K+ pump 
possesses a high number of Cys residues (Siems et al., 1996) and Morel 
and colleagues have demonstrated that 4-HNE treatment significantly 
decreases the Cys content of the Na+/K+ pump, resulting in the loss of 
free -SH groups and -SH group functionality (Morel et al., 1998). 
Similarly, 4-HNE has been shown to alter SERCA2a Ca2+-uptake in a 
biphasic manner, with low concentrations potentially increasing 
SERCA2a activity and higher concentrations inhibiting activity (Tian et 
al., 2014). To date, no study has investigated the effects of 4-HNE on 
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SERCA structure or if SERCA isoforms are differentially affected by 4-
HNE. 
Purpose: 
 The objectives of this thesis are to determine the effects of 4-HNE 
on the structure and function of SERCA1a and SERCA2a pumps. 
Hypothesis: 
1) 4-HNE will dose-dependently impair SERCA pumps upon co-
incubation. This will be demonstrated by a reduction in maximal 
Ca2+-dependent SERCA activity of both SERCA1a (fast skeletal 
muscle) and SERCA2a (left ventricle).  
2) 4-HNE will dose-dependently adduct onto the SERCA1a and 
SERCA2a pump isoforms as measured through Western blotting. 
3) 4-HNE will dose-dependently increase SERCA aggregation as 
illustrated through increased higher molecular weight bands 
(>100kDa) and a reduction in SERCA monomer when Western 
blotting for SERCA1a and SERCA2a after 4-HNE treatment. 
4) 4-HNE treatment will have greater effects on SERCA2a when 
compared to SERCA1a, as illustrated through the above measures. 
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Methods 
Animals 
 Adult (> 10 weeks) C57BL/6J mice were used in this study. These 
animals had access to water and laboratory chow ad libitum and were 
housed in a temperature controlled room on a reverse light/dark cycle 
until tissue collection. Immediately after culling the white portions of the 
gastrocnemius (WG) and whole left ventricle (LV) tissues were excised, 
homogenized in PMSF buffer (250mM sucrose, 5mM HEPES, 0.2mM 
PMSF, and 0.2% NaN3), aliquoted, immediately frozen in liquid nitrogen, 
and subsequently stored at -80 OC until experimental use. The 
experimental protocols were reviewed and approved by the University 
of Waterloo Animal Care Committee.  
4-HNE Treatment Protocol 
To investigate the effects of 4-HNE on the structure and function 
of the SERCA pump, WG and LV whole tissue homogenates were 
incubated with different concentrations of 4-HNE. Initially, 4-HNE (sc-
202019, Santa Cruz Biotechnology) was reconstituted in 2mL of ethanol 
to achieve a concentration of 0.5mg/mL. Upon use, 4-HNE was added 
into disposable glass culture tubes (14-961-25, Fisher Scientific) and dried 
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with gentle heat and nitrogen gas to evaporate the ethanol solution. The 
respective treatment concentrations (0mM, 0.5mM, 1mM, 2.5mM, 5mM, 
and 10mM) were achieved after the addition of different volumes of 4-
HNE, evaporation of ethanol, and subsequent addition of 2.5uL of 
dimethyl sulfoxide (DMSO) (276855-100mL, Sigma-Aldrich) and 10uL of 
muscle homogenate. The samples containing the 4-HNE, DMSO and 
muscle homogenates were treated at room temperature (24 OC) for 1 
hour and gently vortexed at time-points: 0, 30 and 60 minutes during the 
incubation protocol. After treatment, the samples were either assayed for 
maximal SERCA activity or further processed for assessment of post-
translational structural modifications of the SERCA isoforms as 
described below.  
Maximal Ca2+-dependent ATPase activity 
Measurements of Ca2+-dependent SERCA activity were made at 37 
OC using a spectrophotometric assay developed by (Simonides & 
Hardeveld, 1990) that has been adapted to a 96-well plate reader 
(Duhamel et al., 2007). To investigate the effects of 4-HNE on maximal 
SERCA activity, both WG and LV whole tissue homogenates were 
treated with 4-HNE at the respective treatment concentrations. After 
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incubation, 7.5uL of each of the treated samples were then added to 5mL 
of SR Ca2+ ATPase buffer (pH = 7, 200mM KCl, 20mM HEPES, 10mM 
NaN3, 1mM EGTA, 15mM MgCl2, 5mM ATP, and 10mM 
phosphoenolpyruvate (PEP)) and subsequently, 18U/mL of pyruvate 
kinase (PK) (10-128-163-001, Roche), 18U/mL of lactate dehydrogenase 
(LDH) (L2625-25KU, Sigma Life Sciences), and 1 uM calcium ionophore 
A23187 (C-7522, Sigma-Adlrich) were combined in a test tube on ice. The 
cocktail was then vortexed and subdivided (300uL) into 16 
microcentrifuge tubes with varying concentrations of CaCl2, allowing for 
the measurement of Ca2+-dependent maximal SERCA activity. The free 
Ca2+ corresponding to each CaCl2 addition was assessed separately by 
use of single-wavelength spectrofluorometry and the Ca2+-fluorescent 
dye Indo-1 (I-1203, Life Technologies). The range of Ca2+ additions 
translates into a pCa range of ~ 7.0 - 5.0. Next, each of the sixteen 300uL 
subdivisions were loaded in duplicate (100uL) onto a clear round-bottom 
96-well plate. The final step was the addition of 1uL of 1.7% (w/v) 
NADH (13348539, Roche) to each well. The ATPase activity is 
represented by the decrease in NADH (606-68-8, Sigma-Aldrich) 
absorbance at 340nm (SPECTRAmax Plus, Molecular Devices). To 
distinguish Ca2+-ATPase activity from background ATPase activity, 
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240uM of the SERCA specific inhibitor cyclopiazonic acid (CPA) (111258-
00-5, Sigma-Aldrich) was used (Seidler, Jona, Vegh, & Martonosi, 1989). 
The difference between the total activity and the basal activity (activity 
in the presence of CPA) represented the SERCA specific Ca2+-ATPase 
activity. The reaction proceeded for 30 minutes at 37 OC and the rate of 
decline in NADH was kinetically recorded beginning at minute 10 of the 
trial. All values were normalized to total protein concentration as 
determined through the bicinchoninic acid (BCA) assay. The VMax was 
taken as the peak rate of activity, which typically occurred between a 
pCa of 5.5 - 5.0.  
Isolation of SERCA1a and SERCA2a via immunoprecipitation (IP) 
 In order to accurately determine SERCA-specific (SERCA1a and 
SERCA2a) 4-HNE adduction, nitrotyrosine formation, glutathionylation 
and FITC binding capacity, SERCA1a and SERCA2a were 
immunoprecipitated from the treated WG and LV homogenates, 
respectively. This yielded SERCA specific measures and removed other 
possible confounding proteins, as the SERCA pump and Na+/K+ pump 
are both members of the P-type transporter family and are of similar size 
(~100kDa) and 3-D structure (Morth et al., 2007; toyoshima 2000). First, 
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SERCA1a or SERCA2a primary antibodies were coupled with anti-IgG 
coupled agarose beads. Initially, 75µL of the IgG coupled agarose beads 
were washed with phosphate buffered saline (PBS) (ph=7.4, 137mM 
NaCl, 2.7mM KCl, 4.3mM Na2HPO4, and 1.42mM NaH2PO4) and the 
antibodies were subsequently coupled to the agarose bead by adding 
0.5µL or 1µL of SERCA1a or SERCA2a primary antibody, respectively. 
After the addition of the respective antibodies the samples were brought 
to a final volume of 50µL with PBS and subsequently incubated for 2 
hours. After primary incubation, the beads were washed with blocking 
solution (pH=7.4 1% BSA in PBS) by incubating for 15 minutes on ice 
with sporadic shaking. After blocking the beads were washed with PBS 
solution and the antibody coupled agarose beads were then incubated 
with 7.5µL of the treated sample homogenates with 192.5µL of Co-IP 
buffer (pH = 7.4, 150mM NaCl, 20mM HEPES, 1mM EDTA, 10mM 
MgCl2, and 0.5% Tween (v/v)). The cocktail containing the treated 
homogenate and antibody coupled agarose beads were then 
subsequently incubated for 1 hour on an orbital shaker in the fridge at 4 
OC. After incubation, the samples were centrifuged and then washed 
with Co-IP buffer three times and one last time with 0.5mL of wash 
buffer (pH=7.2, 150mM NaCl, 25mM Tris base), the supernatant was 
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discarded. The immunoprecipitated SERCA1a and SERCA2a protein 
were then eluted from the cocktail by adding 36µL of low pH buffer 
(pH= 2.8 100mM glycine) and incubated on ice for 15 minutes. The eluted 
material (containing SERCA1a or SERCA2a as well as the eluted 
antibody) was collected and neutralized with neutralization buffer (pH = 
9.0 1M Tris Base). The samples were then either Western blotted or 
treated with FITC.  
Western Blotting of whole homogenate and IP samples 
To investigate the effects of 4-HNE on SERCA structure, which 
may contribute to changes in SERCA function, both WG and LV whole 
tissue homogenates were subjected to Western blotting following 4-HNE 
treatment (0, 0.25, 1.0, 2.5, 5.0, and 10mM). Samples were either mixed 
with 12.5uL of sample reducing buffer (pH = 6.8, 0.1M Tris-HCl, 45% 
glycerol (v/v), 1mM SDS, 0.037mM bromophenol blue, and 12.5% (v/v) 
B-mercaptoethanol) to detect 4-HNE protein adduction and nitrotyrosine 
formation or with sample non-reducing buffer (pH = 6.8, 0.1M Tris-HCl, 
45% glycerol (v/v), 1mM SDS, and 0.037mM Bromophenol blue) to detect 
protein glutathionylation and SERCA aggregation. A total of 4µL of the 
treated homogenates (~ 35-50µg) were loaded onto 7.5% polyacrylamide 
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gels and separated using standard SDS-PAGE protocols (Laemmli, 1970). 
A molecular weight marker (Precision Plus Protein Western C Standards; 
161-0376, Bio-Rad) was added to identify the molecular weights of the 
separated proteins. The samples were separated using the Bio-Rad 
Power-Pak 200 set at an initial voltage of 100 V for 10-15 minutes and 
then at 120 V for 55-60 minutes for a total time of 70 minutes. After 
electrophoresis, the gels were then transferred onto polyvinylidene 
difluoride (PVDF) membranes (Bio-Rad) using wet-transfer techniques 
and subsequently blocked for 1 hour at room temperature in 5% skim-
milk with Tris-buffered saline plus Tween (TBS-T; Tris-HCl, pH 7.5, 150 
mM NaCl, 0.1% Tween 20) on a tilt-table. After blocking, antibodies for 
4-HNE (MAB3249, Research and Development), 3-nitrotyrosine (189542, 
Cayman Chemicals), glutathionylation (101-A-250, Virogen), SERCA1a 
(kindly donated by Dr. Maclennan), and SERCA2a (MA3-919, Affinity 
BioReagents) were applied for 1 hour at room temperature on a rocker 
table (See Appendix, Table A1). After primary incubation, the 
membranes were washed with TBS-T for a total of 15 minutes (3 washes 
at 5 minutes/wash) and probed for 1 hour with horse-radish peroxidase 
(HRP) conjugated anti-mouse secondary antibody (See Appendix, Table 
A1). After incubation with secondary antibody, the membranes were 
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washed for a total of 15 minutes (3 washes at 5 minutes/wash) with TBS-
T and the images were visualized using ECL Western blotting substrate 
kit  (K820-500-1, BioVision) and a bio-imaging system. Images were 
captured and analyzed using the software GeneSnap and GeneTools 
respectively (Syngene). For whole homogenate Western blots, the signals 
in all of the lanes were normalized to total protein as detected through 
membrane Ponceau staining and subsequently normalized to control 
lanes to yield relative changes respective to total protein load and control 
condition. For immunoprecipitation Western blots, the signals in all of 
the lanes were normalized to their respective SERCA content and 
subsequently normalized to control lanes to yield relative changes 
respective to SERCA load and control condition. 
Determination of FITC binding to SERCA1a or SERCA2a 
FITC binding to SERCA was assessed in immunoprecipitated 
samples following neutralization. After neutralization, the 
immunoprecipitated samples were combined with 80µL of FITC binding 
buffer (pH = 8.8, 50mM Tris-HCl, 250mM sucrose, 0.1mM CaCl2, 5mM 
MgCl2, 20uM FITC and protease inhibitors) and incubated at room 
temperature in the dark for 1 hour. To stop the reaction, reducing buffer 
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was added to each sample. Next, 10µL of each sample were loaded onto 
a 7.5% polyacrylamide gel and separated by SDS-PAGE. The membranes 
were probed with anti-flouroscein/Oregon Green monoclonal antibody 
(4-4-20, Invitrogen) (See Appendix, Table A1) in milk in TBS-T. Lastly the 
membranes were probed with anti-mouse secondary antibody (See 
Appendix, Table A1) and the images were developed using GeneSnap 
(Syngene). The optical density for each of the treatment concentrations 
was normalized to its respective control sample. 
Data Analysis 
All data are expressed as means ± standard error of the mean 
(S.E.). Statistical significance was set to P < 0.05. The statistical analysis 
was carried out using either a one-way repeated measures ANOVA or a 
two-way ANOVA where appropriate. Post-hoc analysis was carried out 
using Tukey’s test for significance. 
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Results 
4-HNE adduction and Ca2+-ATPase activities 
Western blots demonstrated that 4-HNE treatment resulted in a 
significant increase in total protein 4-HNE adduction in both WG and LV 
tissues (Figure 2). In WG, treatment concentrations of 5.0 and 10.0mM 
caused greater 4-HNE adduction compared with CTL, 1.0mM, and 
2.5mM conditions (Fig. 2A and E). In LV, 4-HNE protein adduction was 
increased following treatment with 5.0mM 4-HNE and further increased 
with 10.0mM treatment (Fig. 2B and F). 
Immunoprecipitation of SERCA1a and SERCA2a from WG and 
LV tissues, respectively, demonstrated increased 4-HNE adduction to 
SERCA1a (Fig. 3A and E) with 10mM 4-HNE treatment. Results 
illustrating an approximate 147% increase in 4-HNE – SERCA1a 
adduction when compared to CTL. In contrast, there were no observable 
changes in the SERCA2a isoform (Fig. 3B and F). 
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Figure 2: 4-HNE Western blots for WG and LV tissue. 
 
(A) A representative Western blot of 4-HNE adduction to WG homogenate. (B) A representative 
Western blot of 4-HNE adduction to LV homogenate. (C) A Ponceau stain of the representative 
(WG) Western blot used for normalization to total protein load. (D) A Ponceau stain of the 
representative (LV) Western blot used for normalization to total protein load. (E) Bar graph of 
4-HNE adduction to WG homogenate. (F) Bar graph of 4-HNE adduction to LV homogenate. All 
data are means ± S. E. (WG: n = 9; LV: n = 18)  
*, p < 0.05 versus CTL, 1.0mM and 2.5mM treatment groups; †, p < 0.05 versus all treatment 
groups. 
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Figure 3: 4-HNE Western blots for Immunoprecipitated SERCA1a and SERCA2a. 
 
(A) A representative Western blot of SERCA1a 4-HNE protein adduction. (B) A representative 
Western blot of SERCA2a 4-HNE protein adduction. (C) A Western blot of the 
immunoprecipitated SERCA1a used to normalize for SERCA1a protein load. (D) A Western blot of 
the immunoprecipitated SERCA2a used to normalize for SERCA2a protein load. (E) Bar graph of 
SERCA1a 4-HNE protein adduction (F) Bar graph of SERCA2a 4-HNE protein adduction. All data 
are means ± S. E. (WG: n = 7; LV: n = 9). 
*, p < 0.05 versus CTL group.
 
 
27 
 
 To determine if 4-HNE functionally impairs SERCA activity, WG 
and LV homogenates were assayed for maximal Ca2+-dependent ATPase 
activities following 4-HNE treatment. The dose-dependent effects of 4-
HNE on SERCA function are shown in Figure 4 and Table 1.  In WG, 
there was a trend (p = 0.06) for a lower (~66% relative to CTL) maximal 
SERCA activity following 4-HNE treatment for both 1.0 and 2.5mM 
concentrations; however, 5.0mM 4-HNE treatment caused a significant 
57% decrease in maximal Ca2+-dependent ATPase activity when 
compared with CTL (Fig. 4A and C; Table 1). 4-HNE treatment in LV 
caused a dose-dependent decrease in maximal Ca2+-dependent SERCA2a 
activity beginning at 1.0mM 4-HNE treatment (Fig. 4B and C; Table 1). 
There were no effects of 4-HNE treatment on the apparent Ca2+-affinities 
of SERCA1a and SERCA2a between all treatment conditions (Table 1). 
There were also no differences in the Hill slope (nH) between treatment 
conditions in either WG or LV (Table 1). 
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Figure 4: Ca2+-dependent SERCA activity for SERCA1a and SERCA2a.  
 
(A) pCa curve illustrating Ca2+-dependent maximal SERCA1a activity across 4-HNE treatment concentrations (B) pCa curve illustrating Ca2+-dependent maximal 
SERCA2a activity across 4-HNE treatment concentrations. (C) Bar graph comparing 4-HNE inhibition of both SERCA isoforms relative to their respective CTLs. All 
data are means ± S. E. (WG: n = 6; LV: n = 4).
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Table 1: Effects of 4-HNE on SERCA enzyme kinetics 
WG and LV homogenate was incubated with 4-HNE and maximal Ca2+-dependent SERCA2a activity was subsequently assessed. All data are means ± S. E. (WG: 
n = 6; LV: n = 4). 
 
 
 
*, p < 0.05 compared within their respective CTL & 0.5mM treatment groups; 
†, p < 0.05 compared within all their respective treatment groups. 
 
(WG): CTL versus 1.0mM p=0.06; 
(WG): CTL versus 2.5mM p=0.06.
WG LV WG LV WG LV WG LV WG LV
VMax 755.57 ± 29.4 146.6 ± 6.10 685.36 ± 46.5 145.05 ± 5.23 501.45 ± 74.7 104.28 ± 4.22 * 498.2 ± 71.29 93.34 ± 8.26 * 327.21 ± 52.44 * 45.53 ± 3.98 †
K Ca 6.32 ± 0.10 6.02 ± 0.06 6.41 ± 0.09 5.98 ± 0.08 6.52 ± 0.06 5.99 ± 0.04 6.49 ± 0.07 6.01 ± 0.02 6.38 ± 0.10 6.14 ± 0.09
n H 3.45  ± 0.51 3.50 ± 1.12 3.18 ± 0.31 2.80 ± 0.32 4.18 ± 0.55 2.23 ± 0.20 4.46 ± 1.02 3.70 ± 0.81 2.64 ± 0.39 2.12 ± 0.55
CTL 5.0 mM2.5 mM1.0 mM0.5 mM
4-hydroxy-2-nonenal Treatment Concentration
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Western blot results 
To determine the mechanism(s) responsible for 4-HNE mediated 
impairment of maximal Ca2+-dependent SERCA activity, Western 
blotting was used to measure nitrotyrosine formation, glutathionylation, 
and SERCA aggregation in whole muscle homogenates from WG and LV 
tissue after 4-HNE treatment. There were no detectable increases in total 
nitrotyrosine formation (Figure 5) or glutathionylation (Figure 6) in 
either WG or LV. Western blotting for SERCA1a aggregation in WG 
revealed a significant reduction in SERCA1a monomer levels following 
2.5mM, 5.0mM and 10mM 4-HNE treatment when compared to CTL and 
1.0mM 4-HNE treatment groups (Fig. 7A and E). Corresponding with 
reduced SERCA1a monomer levels, compared with CTL, higher 
molecular weight SERCA1a aggregates were increased by ~400% and 
~800% in samples that were treated with 5.0 and 10.0mM 4-HNE, 
respectively, but only the difference between CTL and 10.0mM 4-HNE 
was significant. (Fig. 7A and G). Western blotting for SERCA2a 
aggregation revealed a significant decrease in SERCA2a monomer levels 
in samples that were treated with 5.0mM and 10.0mM 4-HNE when 
compared to CTL, 1.0mM, and 2.5mM 4-HNE treatment groups (Fig. 7B 
and F). Western blotting for higher molecular weight SERCA2a 
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aggregates revealed higher levels in 2.5mM, 5.0mM and 10.0mM 4-HNE 
treatment groups when compared with CTL (Fig. 7B and H).
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Figure 5: 3-Nitrotyrosine formation Western blots for WG and LV tissue.  
 
(A) A representative Western blot of 3-nitrotyrosine formation to WG homogenate. (B) A 
representative Western blot of 3-nitrotyrosine formation to LV homogenate. (C) A Ponceau 
stain of the representative (WG) Western blot used for normalization to total protein load. (D) 
A Ponceau stain of the representative (LV) Western blot used for normalization to total protein 
load. (E) Bar graph of 3-nitrotyrosine formation to WG homogenate. (F) Bar graph of 3-
nitrotyrosine formation to LV homogenate. All data are means ± S. E. (WG: n = 8; LV: n = 6).
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Figure 6: Glutathionylation Western blots for WG and LV tissue. 
 
(A) A representative Western blot of protein glutathionylation to WG homogenate. (B) A 
representative Western blot of protein glutathionylation to LV homogenate. (C) A Ponceau 
stain of the representative (WG) Western blot used for normalization to total protein load. (D) 
A Ponceau stain of the representative (LV) Western blot used for normalization to total protein 
load. (E) Bar graph of glutathionylation to WG homogenate. (F) Bar graph of glutathionylation 
to LV homogenate. All data are means ± S. E. (WG: n = 8; LV: n = 12).
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Figure 7: SERCA aggregation Western blots for WG and LV tissue. 
 
(A) A representative Western blot of SERCA1a in WG homogenate. (B) A representative 
Western blot of SERCA2a in LV homogenate. (C) A Ponceau stain of the representative (WG) 
Western blot used for normalization to total protein load. (D) A Ponceau stain of the 
representative (LV) Western blot used for normalization to total protein load. (E) Bar graph of 
SERCA1a monomer. (F) Bar graph of SERCA2a monomer. (G) Bar graph of SERCA1a aggregates 
(>100kDa). (H) Bar graph of SERCA2a aggregates (>100kDa). All data are means ± S. E. (WG: n = 
6; LV: n = 8). 
*, p < 0.05 versus CTL and 1.0 mM treatment groups; †, p < 0.05 versus CTL, 1.0 mM and 2.5 
mM treatment groups; ‡, p < 0.05 versus CTL treatment group. 
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To determine if 4-HNE causes SERCA specific post-translational 
modifications, SERCA1a and SERCA2a were immunoprecipitated from 
WG and LV tissues, respectively. Western blotting of 
immunoprecipitated SERCA1a and SERCA2a revealed no increases in 
nitrotyrosine formation of either SERCA isoform (SERCA1a: Fig. 8C and 
I; SERCA2a Fig. 8D and J). Additionally, there were no detected 
increases in SERCA specific glutathionylation in either isoform 
(SERCA1a: Fig. 8E and K; SERCA2a: Fig. 8F and L). Interestingly, FITC 
binding assays demonstrated a reduction in FITC binding to SERCA1a 
with 5.0mM and 10.0mM 4-HNE treatment (Fig. 8G and M). There were 
no observed changes in FITC binding to the SERCA2a isoform with 4-
HNE treatment (Fig. 8H and N). 
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Figure 8: Western blots for Immunoprecipitated SERCA1a and SERCA2a. 
 
(A) A Western blot of the immunoprecipitated SERCA1a used to normalize for SERCA1a protein 
load. (B) A Western blot of the immunoprecipitated SERCA2a used to normalize for SERCA2a 
protein load. (C) A representative Western blot of SERCA1a nitrotyrosine formation. (D) A 
representative Western blot of SERCA2a nitrotyrosine formation. (E) A representative Western 
blot of SERCA1a glutathionylation. (F) A representative Western blot of SERCA2a 
glutathionylation. (G) A representative Western blot of SERCA1a FITC binding. (H) A 
representative Western blot of SERCA2a FITC binding. (I) Bar graph of SERCA1a nitrotyrosine 
formation. (D) Bar graph of SERCA2a nitrotyrosine formation. Data are means ± S. E. (WG: n = 
6; LV: n = 6). (K) Bar graph of SERCA1a glutathionylation. (L) Bar graph of SERCA2a 
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glutathionylation. Data are means ± S. E. (WG: n = 6; LV: n = 6). (M) Bar graph of SERCA1a FITC 
binding. (D) Bar graph of SERCA2a FITC binding. Data are means ± S. E. (WG: n = 3; LV: n = 6). 
*, p < 0.05 versus CTL treatment group.
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Discussion 
This study utilized mouse WG and LV to investigate the effects of 
4-HNE on SERCA1a and SERCA2a Ca2+-dependent maximal ATPase 
activities, respectively. Additionally, the structural integrity and post-
translational modifications of SERCA were investigated to identify 
potential mechanisms of 4-HNE mediated SERCA impairment. To 
determine an appropriate treatment protocol the methods were 
originally adapted from Tian and colleagues (Tian et al., 2014). The 
treatment range of 4-HNE was determined from studies illustrating that 
concentrations of 5 - 10 mM were near maximal pathophysiological 
concentrations that 4-HNE would reach in-vivo (Esterbauer, Schaur, & 
Zollner, 1991; Smathers, Galligan, Stewart, & Petersen, 2011; Uchida, 
2003). As hypothesized, 4-HNE incubation caused an increase in 4-HNE 
– protein adduction (Figure 2) and 4-HNE – SERCA1a adduction (Fig. 3A 
and E) in 4-HNE treated samples. These results are consistent with other 
studies reporting 4-HNE – protein adducts (Uchida, 2003; Uchida et al., 
1993); however, purification of SERCA2a from LV treated homogenates 
revealed no significant increases in 4-HNE – SERCA2a adducts (Fig. 3B 
and F). This is the first study to-date demonstrating increased 4-HNE 
adduction to the SERCA pump; however, because only SERCA1a had 
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significantly increased 4-HNE adducts, these results reveal that 4-HNE 
potentially causes isoform specific changes upon co-incubation with 
SERCA. 
As expected, 4-HNE treatment resulted in reductions of maximal 
SERCA1a and SERCA2a Ca2+-ATPase activities in WG and LV tissues, 
respectively (Figure 4; Table 1). In the only other study to date that 
examined the effects of 4-HNE on SERCA function, Tian and colleagues 
report similar findings, in that 4-HNE treatment dose-dependently 
reduced SR Ca+-uptake in re-suspended cellular vesicles from rat heart; 
however, they were unable to detect 4-HNE adducts onto the SERCA2a 
pump (Tian et al., 2014). Additionally, in vitro studies have examined the 
effects of 4-HNE on the structure and function of the Na+/K+ pump 
(Morel et al., 1998); the Na+/K+ and SERCA pumps are of similar size 
(~100kDa) and 3-D structure (Morth et al., 2007; Toyoshima, 2000). 
Similarly, Morel and colleagues demonstrate that 4-HNE treatment to rat 
synaptosomes results in a dose-dependent reduction of Na+/K+ pump 
activity (Morel et al., 1998). Therefore, the observed reductions in 
maximal SERCA1a and SERCA2a activity confirm our hypothesis and is 
in agreement with the current literature; whereby, 4-HNE is a bioactive 
molecule capable of inhibiting protein function. 
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Prior research has established that SERCA can be inactivated 
through nitrosylation, carbonylation, glutathionylation, and aggregation 
of the pump (Adachi et al., 2004; Fu & Tupling, 2009; Senisterra et al., 
1997). 4-HNE treatment and the resulting impairments in SERCA 
function were independent of protein and SERCA specific nitrotyrosine 
formation (Fig. 5; Fig. 8I and J) and glutathionylation (Fig. 6; Fig. 8K and 
L); however, we did observe increased SERCA1a and SERCA2a 
aggregates following 4-HNE treatment (Figure 7). The increased SERCA 
aggregation is expected and in agreement with our hypothesis. 4-HNE is 
documented to cause structural destabilization and protein crosslinking 
leading to protein aggregation (Zarkovic, Cipak, Jaganjac, Borovic, & 
Zarkovic, 2013). Furthermore, 4-HNE is extremely reactive towards Cys 
residues which is the predominate mechanism by which SERCA is 
inactivated through free-radicals. Therefore, 4-HNE oxidizing Cys 
residues and causing SERCA aggregation could be the leading 
mechanism causing the observed 4-HNE induced SERCA inactivation.  
Interestingly, there were isoform specific structural changes 
following 4-HNE treatment; SERCA1a had reductions in FITC binding 
(Fig. 8G and M). The observed reductions of FITC binding to SERCA1a 
reinforce the notion that 4-HNE induces structural destabilization of 
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proteins, as the reductions of FITC binding indicate structural 
destabilization of the SERCA1a nucleotide binding domain. 
Interestingly, FITC binding to SERCA2a was preserved in 4-HNE treated 
homogenates which was unexpected. The preserved FITC binding to 
SERCA2a could potentially be explained by Hsp70. Hsp70 is a 
cytoprotective molecule that can bind to both SERCA1a and SERCA2a 
isoforms (Fu & Tupling, 2009; Tupling et al., 2004), preserving SERCA 
function in conditions of enhanced oxidative stress. Hsp70 is 
constitutively expressed in both skeletal and cardiac muscle but in 
skeletal muscle, its expression tends to coincide with oxidative type I/IIA 
muscle fibres (Locke, Noble, & Atkinson, 1991; Neufer et al., 1996; 
Tarricone et al., 2008; Tupling, Bombardier, Stewart, Vigna, & Aqui, 
2007). Therefore, because mouse WG is predominantly fast-twitch type 
IIB (Bloemberg & Quadrilatero, 2012), the differences in FITC binding 
capacity could be attributed to Hsp70 expression; whereby, Hsp70 was 
able to preserve SERCA2a’s N-domain through direct binding to the 
pump. In contrast, SERCA1a’s N-domain was potentially destabilized 
because mouse WG does not endogenously express appreciable levels of 
Hsp70. Overall, it can be concluded that the structural destabilization of 
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SERCA1a’s N-domain at least partially explains the inactivation of 
SERCA1a caused by 4-HNE treatment. 
4-HNE treatment to WG and LV homogenates resulted in 
increased 4-HNE adduction to SERCA1a (Fig. 3A and E) but not to 
SERCA2a (Fig. 3B and F). These isoform specific changes can be 
explained by the cellular contents of reduced GSH in WG and LV tissue, 
respectively. The WG contains less reduced GSH than LV tissue (Lancel 
et al., 2009). Reduced GSH is the predominant mechanism that protects 
against 4-HNE stress as 4-HNE can directly adduct onto GSH producing 
4-HNE – GSH conjugates, preventing 4-HNE adduction to other cellular 
proteins (Ålin, Danielson, & Mannervik, 1985; Sinha-Hikim et al., 2011; 
Yang, Sharma, Sharma, Awasthi, & Awasthi, 2003). This conclusion is 
supported by the observed ~40-fold increase in 4-HNE adduction to total 
protein in WG (Fig. 2A and E) versus the ~13-fold increase in LV (Fig. 2B 
and F) with 10mM 4-HNE treatment, potentially illustrating GSH’s 
buffering capacity against 4-HNE toxicity in LV homogenates.  
Remarkably, when comparing the relative changes of maximal 
Ca2+-dependent SERCA activities between the SERCA1a and SERCA2a 
isoforms, there were no significant differences in the degree of 
 
 
43 
 
impairments in response to 4-HNE treatment (Fig. 4C); observations 
which disagree with our hypothesis. However, these results could be 
interpreted differently in that SERCA2a displayed similar levels of 
inhibition even in the presence of higher reduced GSH and Hsp70 
cellular content. In that context, SERCA2a may actually be more 
susceptible to 4-HNE mediated inactivation than SERCA1a which would 
be consistent with the general observation that SERCA2a is more 
susceptible to oxidation than SERCA1a (Viner et al., 1996). Initially, to 
directly test this hypothesis, plasmids containing either SERCA1a or 
SERCA2a cDNAs could be transfected into HEK-293 cells and cultured. 
The SERCA1a and SERCA2a containing HEK-293 cells could then be 
treated with 4-HNE and subsequently assayed for their respective 
maximal Ca2+-dependent ATPase activities. If SERCA2a is more 
susceptible to 4-HNE inhibition, then it would be expected that there 
would be greater reductions in SERCA2a activity than SERCA1a activity 
when compared to their respective controls. Testing both isoforms in the 
same cellular niche overcomes limitations with respect to the cellular 
environment, as the cellular expression of GSH and Hsp70 would be 
consistent within both SERCA1a and SERCA2a expressing HEK-293 
cells.  
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Summary and Conclusions 
 In summary, this study illustrates that 4-HNE inhibits SERCA1a 
and SERCA2a maximal Ca2+-dependent ATPase activities independent of 
nitrosylation or glutathionylation of the SERCA pumps. 4-HNE 
treatment to WG and LV homogenates resulted in increased 4-HNE 
adduction to SERCA1a but not to SERCA2a, respectively. In addition, 4-
HNE treatment resulted in significant increases in SERCA aggregation 
for both isoforms but reductions in FITC binding were only observed for 
SERCA1a. The predominant mechanism by which 4-HNE inhibits 
SERCA function is likely through destabilization and aggregation of the 
pumps; however, there are distinct isoform specific structural 
modifications caused by 4-HNE that likely contribute to functional 
impairments of the respective isoforms. 
Limitations 
There are a variety of limitations for this study. First, Western 
blotting techniques for protein carbonyl formation are non-specific, as 
standard DNPH and BH methods detect reactive carbonyl groups, 4-
HNE, ACR, and MDA (Vasquez-Garzon et al., 2012). Therefore, due to 
this limitation, Western blotting was not recruited in measuring the 
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potential for enhanced ROS production and resulting SERCA 
inactivation with 4-HNE treatment. Secondly, Hsp70 expression and 
GSH content in WG and LV were not assessed in this study, so their role 
in explaining the differences between the SERCA isoforms are only 
speculative. Thirdly, we were unable to detect increased 4-HNE 
adduction to the SERCA2a isoform; therefore, our conclusions are 
limited as it cannot be definitively stated that 4-HNE directly adducted 
to and impaired SERCA2a function in our experiments. However, the 
inability to detect 4-HNE adduction to the SERCA2a isoform in our 
experiments may be a limitation with respect to the purification methods 
that were used. Lastly, there is currently no easy method to assessing the 
structural integrity of the high-affinity Ca2+-binding region within the 
SERCA pump. 4-HNE is a small electrophilic and hydrophobic molecule; 
therefore, it is capable of diffusing through membranes which would 
allow it to potentially adduct onto the Ca2+-binding region; thereby, 
causing structural destabilization and damage to the Ca2+-binding sites 
and impairing SERCA function.  
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Future directions 
With relevance to SERCA function, it would be of interest to 
confirm our hypothesis and identify if Hsp70 and GSH can protect 
against 4-HNE induced SERCA inactivation. As previously mentioned, 
this can be assessed by treating HEK-293 cells expressing either 
SERCA1a or SERCA2a with 4-HNE and subsequently assaying them for 
their respective maximal Ca2+-ATPase activities. Additionally, 
unpublished results from our lab indicate that sarcolipin (Sln), a 
micropeptide that binds within the transmembrane region of the SERCA 
pump, potentially protects SERCA from thermal inactivation. Therefore, 
it would be of interest to identify if Sln can also protect against 4-HNE 
induced SERCA impairment. This can be assessed by treating soleus 
muscles with 4-HNE from WT and SlnKO mice and subsequently assaying 
their respective maximal Ca2+-ATPase activities. 
Similar to free-radicals, 4-HNE rapidly oxidizes Cys residues 
(Petersen & Doorn, 2004; Schaur, 2003). However, this has yet to be 
demonstrated in SERCA pumps. It would be of interest to identify if 4-
HNE significantly oxidizes Cys residues of the pump, which can be 
assessed by performing BIAM (N-(Biotinoyl)-N’-
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(lodoacetyl)Ethylenediamine) labeling studies. BIAM is a probe that 
labels free -SH groups, so reductions in BIAM labeling would be 
expected with 4-HNE treatment. Additionally, free-radical oxidation of 
Cys residues has been demonstrated to impair SERCA function; 
interestingly, studies have shown that free-radical SERCA impairment 
can be reversed through the addition of reducing agents. Therefore, it 
would be of interest to see if the addition of reducing agents such as 
dithiothreitol (DTT) can reverse the 4-HNE mediated SERCA 
impairments. Additionally, recruiting other methods of protein 
purification to establish 4-HNE adduction to SERCA2a would provide 
supporting evidence illustrating direct 4-HNE inhibition of the SERCA2a 
isoform. There is a growing trend towards the use of magnetic beads 
rather than sepharose beads in immunoprecipitation, due to their ease, 
reproducibility, and yield; therefore, using magnetic beads in subsequent 
experiments could potentially reveal increased 4-HNE adduction to the 
SERCA2a isoform. Also, it must be noted that the antibody used to 
detect 4-HNE adducts was directed against 4-HNE – His adducts; which 
are less reactive towards 4-HNE when compared to Cys residues. 
Therefore, using an antibody directed against 4-HNE – Cys residues 
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would be more beneficial when attempting subsequent experiments with 
the SERCA2a isoform. 
SERCA impairment has been implicated in endothelial 
dysfunction and cardiovascular disease (Adachi et al., 2004; Cohen & 
Adachi, 2006; Hobai et al., 2013; Knyushko et al., 2005). Therefore, it 
would be of interest to identify if 4-HNE is involved in the 
pathophysiology of these diseases. This can be initially assessed by 
performing Western blots to see if there is increased 4-HNE adduction to 
SERCA2b and SERCA2a isoforms in endothelial and cardiovascular 
diseases, respectively. Furthermore, SERCA aggregation should also be 
recruited to confirm the mechanism of 4-HNE induced SERCA 
impairment in these disease models.
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Appendices 
Table A-1: Western blot antibody dilutions 
 
* All antibodies were diluted using 5% skim-milk with Tris-buffered saline plus 0.1% 
Tween20 
 
 
 
 
 
Antibody Measure WG LV
4-HNE-Histidine 1
O      
1:2000 1
O      
1:2000
2O      1:2000 2O      1:2000
Nitrotyrosine 1
O      
1:2000 1
O      
1:2000
2O      1:2000 2O      1:2000
Glutathionylation 1
O      1:2000 1O      1:2000
2
O      
1:2000 2
O      
1:2000
SERCA1a 1
O      1:10000
2
O      
1:20000
SERCA2a 1
O      
1:2000
2O      1:2000
SERCA1a SERCA2a
4-HNE-Histidine 1O      1:10000 1O      1:10000
2O      1:20000 2O      1:20000
Nitrotyrosine 1
O      
1:10000 1
O      
1:10000
2
O      
1:20000 2
O      
1:20000
Glutathionylation 1O      1:10000 1O      1:10000
2O      1:20000 2O      1:20000
FITC 1
O      
1:5000 1
O      
1:5000
2
O      
1:2000 2
O      
1:2000
Whole Homogenate
Primary & Secondary Antibody Dilutions
Immunoprecipitated
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